Icon

AXUMIN (nda208054)- (9-221mCi/ML)

FLUCICLOVINE F-18 BLUE EARTH
9-221mCi/ML
No No
2042-Apr-23 2021-May-27
None None
None No
Axumin is a radioactive diagnostic agent indicated for positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence based on elevated blood prostate specific antigen (PSA) levels following prior treatment.
0 0 0
Total Other Developers None
Drugs with Suitability No
9-221mCi/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.